2017 APSR Congress
Scientific Programme
Saturday 25 November 2017
- 07:30 - 08:45
Sponsored Breakfast Session 1: Evolving treatment strategies in COPD: What's on the horizon? Sponsored by Novartis
Room: Theatrette 1, Exhibition Hall- 07:30 - 07:35
Introduction - objectives
Speaker: David Price, Singapore - 07:35 - 07:55
Shaping the evolution: Key evidence driving COPD treatment strategies?
Speaker: Peter Barnes, UK - 07:55 - 08:10
Can we switch treatment? What's the evidence?
Speaker: Wisia Wedzicha, UK - 08:10 - 08:25
ICS: The right patient at the right time
Speaker: David Price, Singapore - 08:25 - 08:30
Summary and close
Speaker: David Price, Singapore - 08:30 - 08:45
Chair-led expert discussion and audience Q&Amp;A
Speaker: All speakers
- 07:30 - 07:35
Sponsored Breakfast Session 2: Tackling today's challenges in asthma management: Recent updates and advances Sponsored by TEVA
Room: Theatrette 2, Exhibition Hall- 07:30 - 07:40
Welcome and introduction
Speaker: Helen Reddel, AU - 07:40 - 08:00
This program currently is under development and is subject to change The right inhaler for the right patient: How much does it matter?
Speaker: Peter Wark, AU - 08:00 - 08:20
Unravelling the underlying pathologies of severe asthma
Speaker: Fan Chung, UK - 08:20 - 08:45
Q&Amp;A
Speaker: All speakers
- 07:30 - 07:40
- 09:00 - 10:30
Clinical Allergy Immunology: The changing face of allergy
Room: Cockle Bay 1- 09:00 - 09:30
Environmental effects on immunity and atopy/asthma risk: Lessons from Amish and Hutterite farm children
Speaker: Anne Sperling, US - 09:30 - 10:00
Emerging role of allergen components in food allergy diagnosis
Speaker: Leung Ting Fan, Hong Kong - 10:00 - 10:30
Novel immunotherapy for allergy
Speaker: Jo Douglass, AU
- 09:00 - 09:30
Clinical Respiratory Medicine / Environmental and Occupational Health: The lung in a challenging environment
Room: Cockle Bay 2- 09:00 - 09:30
ET: The lung in microgravity and space
Speaker: Kim Prisk, US - 09:30 - 10:00
Supersize me; the effect of morbid obesity on lung function
Speaker: Norbert Berend, AU - 10:00 - 10:30
Lungs on a plane: Travel risk assessment in patients with cardiorespiratory disease
Speaker: Leigh Seccombe, AU
- 09:00 - 09:30
Lung Cancer 2: New approaches in lung cancer
Room: Darling Harbour Theatre- 09:00 - 09:30
Sorting the Update on CT Screening; monitoring of SPNs and GGOs
Speaker: Fraser Brims, AU - 09:30 - 10:00
Can sublobar resection be done as a radical resection for small-sized non-small cell lung cancer?: A JCOG strategy
Speaker: Hisao Asamura, Japan - 10:00 - 10:30
Monitoring patients after curative lung cancer treatments: Current guidelines and newer evidence
Speaker: Emily Stone, AU
- 09:00 - 09:30
Oral Presentations: Clinical Respiratory Medicine 2
Room: E3.1- 09:00 - 09:10
Non-Invasive Ventilation in Motor Neurone Disease/Amyotrophic Lateral Sclerosis: An Australasian Perspective
Speaker: Wai Kuen Chow, NSW - 09:10 - 09:20
Clinical Investigation for the Efficacy of Pulse Oxi-Capnometer "Capno-Eye" in Respiratory Failure Patients-Comparison between PACO2, PVCO2, PTCCO2 and ETCO2
Speaker: Shota Fujimoto, Japan - 09:20 - 09:30
Obesity is an Independent Risk Factor for Obstructive Sleep Apnea in Children
Speaker: Tingting Xu, China - 09:30 - 09:40
Clinical Course and Outcome of Immunoglobulin G4 Related Lung Disease
Speaker: Shinhee Park, Republic of Korea - 09:40 - 09:50
Simple Pleural Manometry using Existing Pleural Drainage System: Experience of Two Cases of Pleural Effusions with Post-Drainage Unexpandable Lung and Pneumothorax Ex Vacuo
Speaker: Geak Poh Tan, Singapore - 09:50 - 10:00
Relationship of Pleural Fluid Ph and Glucose: A Multi-Centre Study of 2971 Cases
Speaker: Deirdre Fitzgerald, WA - 10:00 - 10:10
Assessment of US Electronic Medical Records to Guide Feasibility and Design of the Novelty Study
Speaker: Helen Reddel, AU - 10:10 - 10:25
Baseline predictors of non-invasive ventilation use in amyotrophic lateral
Speaker: Jason Ackrivo, US
- 09:00 - 09:10
Oral Presentations: COPD 3
Room: E3.4- 09:00 - 09:30
Extra-pulmonary morbidities and COPD exacerbations
Speaker: Shigeo Muro, Japan - 09:30 - 09:40
The Prevalence of COPD in England: An Ontological Approach to Case Detection in
Primary Care
Speaker: Louise Rayner, AU - 09:40 - 09:50
Feasibility Analysis of Nebulized Budesonide used for COPD Exacerbations Initial Treatment: A Post Hoc Analysis of a Non-Interventional, Retrospective, Observational Study
Speaker: Jinping Zheng, China - 09:50 - 10:00
Estimating the Number of Patients Needed to Treat (NNT) with Indacaterol/Glycopyrronium to Prevent COPD Exacerbations: Results from the Flame Study
Speaker: Jadwiga A Wedzicha, UK - 10:00 - 10:10
Once-Daily Inhaled Umeclidinium/Vilanterol Combination Therapy Compared with Placebo on Exacerbations in Chinese Patients with COPD
Speaker: Jinping Zheng, China - 10:10 - 10:20
Effect of Erdosteine on the Rate of COPD Exacerbations In Spirometrically Defined Gold II Patients
Speaker: Peter Calverley, UK
- 09:00 - 09:30
Oral Presentations: Interstitial Lung Disease 1
Room: E3.10- 09:00 - 09:10
Distribution of Honeycombing Area using Quantitative CT Analysis Effects the Mortality in IPF
Speaker: Hiroaki Nakagawa, Japan - 09:10 - 09:20
Antifibrotic Drug Target Protein (RXFP1) is Expressed in Idiopathic Pulmonary Fibrosis Lungs
Speaker: Simon Royce, AU - 09:20 - 09:30
Bleomycin-Induced Lung Epithelial Cell Injury is Associated with G2/M Cell Cycle Arrest via Schlafen Axis
Speaker: Soojin Jang, Republic of Korea - 09:30 - 09:40
Idiopathic Pulmonary Fibrosis in Never Smokers
Speaker: Daisuke Akahori, Japan - 09:40 - 09:50
Japanese First Guideline for the Treatment of Idiopathic Pulmonary Fibrosis 2017
Speaker: Sakae Homma, Japan - 09:50 - 10:00
Eligibility for Anti-Fibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Depends on the Predictive Equation used in Pulmonary Function Testing
Speaker: Ken Goon, AU - 10:00 - 10:10
Long-Term Nintedanib Treatment In Idiopathic Pulmonary Fibrosis (IPF)
Speaker: Jin Woo Song, Republic of Korea - 10:10 - 10:20
Acute Exacerbation of Idiopathic Pulmonary Fibrosis by New Definition: Incidence, Risk Factors and Outcome
Speaker: Jehun Kim, Republic of Korea - 10:20 - 10:30
Association of serum KL-6 and CA15-3 levels and connective tissue disease-related interstitial pneumonia (CTD-ILD)
Speaker: Zijun Guo, China
- 09:00 - 09:10
Oral Presentations: Respiratory Infections (Non-TB) 3
Room: E3.1- 09:00 - 09:25
Management of pneumonia-related sepsis in the community hospital setting
Speaker: John Studdard, USA - 09:25 - 09:35
Analysis of Mutation Associated with Macrolide Resistance in Bordetella Pertussis in Okinawa, Japan
Speaker: Saifun Nahar, Japan - 09:35 - 09:45
Macrolides Protect Against Pseudomonas Aeruginosa Infection via Inhibition of Inflammasomes
Speaker: Jin-Fu Xu, China - 09:45 - 09:55
The Impact of Cigarette Smoke Exposure on Lung Fibroblastic Response after Influenza Pneumonia
Speaker: Seiwon Lee, Republic of Korea - 09:55 - 10:05
Change in Lung Function in Never-Smokers with Non-Tuberculous Mycobacterial Lung Disease
Speaker: Takehiko Kobayashi, Japan
- 09:00 - 09:25
- 10:30 - 11:00
Morning Tea and Exhibition Viewing
- 11:00 - 12:00
Plenary: Presidential Lecture
Room: Darling Harbour Theatre- 11:00 - 11:20
Lung cancer in 2017
Speaker: Kwun Fong, AU - 11:20 - 11:40
Seeing is believing - novel imaging techniques for understanding lung diseases
Speaker: Jane Bourke, AU - 11:40 - 12:00
An end game for tobacco
Speaker: Matthew Peters, AU
- 11:00 - 11:20
- 12:00 - 13:15
Lunch and Exhibition Viewing
Room: Exhibition Hall Sponsored Lunchtime Session 1: Treating small airways: A step further in asthma and COPD management Sponsored by Chiesi-Emerge Health
Room: Theatrette 1, Exhibition Hall- 12:00 - 12:20
Asthma and COPD: What is the connection with small airways?
Speaker: Christine Jenkins, AU - 12:20 - 13:00
Improving outcomes in asthma and COPD with an extra-fine ICS+LABA combination
Speaker: Alberto Papi, Italy - 13:00 - 13:15
Closing
- 12:00 - 12:20
Sponsored Lunchtime Session 2: Respiratory medical evidence: The ins and outs of validity Sponsored by GSK
Room: Theatrette 2, Exhibition Hall- 12:00 - 12:05
Introduction
Speaker: Peter Gibson, AU - 12:05 - 12:30
Real life research and its relevance to respiratory medicine
Speaker: Helen Reddel, AU - 12:30 - 13:00
Effectiveness in everyday practice: The Salford lung study
Speaker: David Leather, UK - 13:00 - 13:15
Panel discussion and Q&Amp;A
Speaker: All speakers
- 12:00 - 12:05
- 13:15 - 14:45
Clinical Respiratory Medicine 1: Breathlessness
Room: Darling Harbour Theatre- 13:15 - 13:30
A teachable construct for the evaluation of the breathless patient
Speaker: Matthew Peters, AU - 13:30 - 13:55
CPET in the evaluation of breathlessness
Speaker: Adrian Chan, Singapore - 13:55 - 14:20
Pharmacological management of breathlessness in established chronic lung disease
Speaker: Darcy Marciniuk, Canada - 14:20 - 14:45
Pulmonary rehabilitation in chronic lung disease
Speaker: Anne Holland, AU
- 13:15 - 13:30
Respiratory Infections (Non-TB) 1: Bronchiectasis
Room: Cockle Bay 2- 13:15 - 13:45
Bronchiectasis in asthma and COPD
Speaker: Jinfu Xu, China - 13:45 - 14:15
Paediatric bronchiectasis in indigenous populations
Speaker: Anne Chang, AU - 14:15 - 14:45
Management of NTM Infections
Speaker: Rachel Thomson, AU
- 13:15 - 13:45
Respiratory Neurobiology and Sleep 2: Management and consequences of sleep apnea
Room: Cockle Bay 1- 13:15 - 13:45
Associations between OSA and obesity before and following CPAP treatment or sleep duration
Speaker: Kazuo Chin, Japan - 13:45 - 14:15
An ambulatory approach versus hospital based approach in managing patients with suspected OSA
Speaker: David Hui, Hong Kong - 14:15 - 14:45
Understanding upper airway anatomy in OSA - can we predict response to oral appliances?
Speaker: Peter Cistulli, AU
- 13:15 - 13:45
Oral Presentations: Clinical Allergy and Immunology / Paediatric
Room: E3.4- 13:15 - 13:25
Childhood Asthma Development in Relation with Perinatal and Environmental Factors
Speaker: Taehoon Lee, Republic of Korea - 13:25 - 13:35
The Application of sIgE/sIgG4 and IFN-Y in Infantile Allergy March
Speaker: Jiaying Luo, China - 13:35 - 13:45
Peanut Sensitivity and Allergic Rhinitis at 6 Years of Age are Associated with Increased Symptoms of Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder Later in Life
Speaker: Ho-chang Kuo, Taiwan - 13:45 - 13:55
Critical Evaluation of Scientific Content in Pediatric Respiratory Guidelines in China
Speaker: Jiang Mei, China - 13:55 - 14:05
Development of an In-Vitro Mucus Model to Evaluate the Effect of Magnesium on Current Mucolytic Therapies for Cystic Fibrosis Treatment
Speaker: Mariam Mamlouk, AU - 14:05 - 14:15
Allergen Immunotherapy Might Reduce Basophil Response in House Dust Mite Allergic Patients
Speaker: Mulin Feng, China - 14:15 - 14:25
Blood Levels Of Group 2 Innate Lymphoid Cells In Children With Acute Wheeze
Speaker: Aayushi Sen, UK
- 13:15 - 13:25
Oral Presentations: Environmental and Occupational Health and Epidemiology
Room: E3.10- 16:15 - 16:25
Factors Associated with Pneumococcal Vaccination among the Elderly at Elderly Clubs in Miyakonojo City, Miyazaki Prefecture, Japan
Speaker: Akihiro Sakamoto, Japan - 16:25 - 16:35
Smoking Behaviour Among Metro North Hospital and Health Services Employees
Speaker: Mridula Mokoonlall, AU - 16:35 - 16:45
Vaping Knowledge, Attitude and Practice Amongst General Public in Malaysia
Speaker: Ahmad Izuanuddin Ismail, Malaysia - 16:45 - 16:55
Occupational Exposure to Solvents and Metals and Fixed Airflow Obstruction in Women
Speaker: Sheikh Alif, AU - 16:55 - 17:05
Lung Function and Long-Term Exposure to PM10 And NO2 In A COPD Cohort
Speaker: Woo-Jin Kim, Republic of Korea - 17:05 - 17:15
Elevated Expression of MIR-691,MIR-181A,MIR-146A and MIR-21 Involved in Regulating TH1/TH2 Balance with Acute Exposure of Fine Particulate Matter in Mice
Speaker: Tian-Fang Hou, China - 17:15 - 17:25
Comparison of Asbestos Fiber Detection Methods in Bal Fluid and Lung Tissue of Rat
Speaker: Mirae Jang, Republic of Korea - 17:25 - 17:35
Circular RNA Mediates Silica-Induced Macrophage Activation via HECTD1 Dependent Ubiquitination
Speaker: Zewei Zhou, China
- 16:15 - 16:25
Poster Session
Room: Exhibition Hall- 14:45 - 15:15
Afternoon Tea and Exhibition Viewing
- 18:30 - 19:00
Pre-Dinner Drinks
Room: Ballroom Foyer - 19:00 - 23:55
Gala Dinner
Room: Grand Ballroom
